Protein modification by aldehydophospholipids and its functional consequences. - Wikidata - wikimedia - TriplyDB

Protein modification by aldehydophospholipids and its functional consequences.

Protein modification by aldehydophospholipids and its functional consequences.

http://www.wikidata.org/entity/Q37997263

about

Protein lipoxidation: Detection strategies and challenges Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation.Effects of oxidized phospholipids on gene expression in RAW 264.7 macrophages: a microarray study.Identification of carbonylated lipids from different phospholipid classes by shotgun and LC-MS lipidomics.Toxicity of oxidized phospholipids in cultured macrophages Oxidized Phospholipids Inhibit the Formation of Cholesterol-Dependent Plasma Membrane Nanoplatforms.Interaction of aldehydes derived from lipid peroxidation and membrane proteins Physical damage on giant vesicles membrane as a result of methylene blue photoirradiation Role of phospholipid oxidation products in atherosclerosis.Oxidized phosphatidylcholines in membrane-level cellular signaling: from biophysics to physiology and molecular pathology.Demonstration of HNE-related aldehyde formation via lipoxygenase-catalyzed synthesis of a bis-allylic dihydroperoxide intermediate.Separation and characterization of oxidized isomeric lipid-peptide adducts by ion mobility mass spectrometry.NaV1.9 Potentiates Oxidized Phospholipid-Induced TRP Responses Only under Inflammatory Conditions.Antinociception by the anti-oxidized phospholipid antibody E06.How Does Membrane Oxidation Affect Cell Delivery and Cell Killing?Macrophage phenotype and bioenergetics are controlled by oxidized phospholipids identified in lean and obese adipose tissue

P2860

Q26824737-C873FB20-FAB2-4FE1-A6FC-671DF969781D Q33906276-AF17A63A-D8E4-4FEA-A6CE-9D886BF6DAA7 Q34379725-328FA6BB-FCDC-4B8C-AF1D-7F02DFD214E0 Q35564833-97E9FFF0-8C4B-4FD9-AC83-E5C029F286E1 Q36498570-6D8D57EC-FB03-4C1B-A8D1-55D382E06A87 Q36724276-A7E9E6D6-4ECB-401B-9BD9-75C7D83A1557 Q37142547-78829AC9-8924-4D7F-B9C7-C02A980424AA Q37533480-0B36206D-EE31-45C5-9692-B47BEE51760F Q38039282-EC8A6F3A-57CF-4856-858D-9670FFB09A08 Q38090702-4E1B1F0D-CF96-42AB-AE4C-B685F588E3C4 Q43080743-E2E29F22-3183-494F-9E5A-F0759AC56B4E Q46628472-52A73D34-549A-4730-8F7D-B24611227983 Q49577397-73D7B326-8679-46E2-BAE7-E15E126C04DD Q52313596-89770DAC-6D4E-4CF4-948A-CCA440B91F92 Q53499530-36019A1E-2D00-4C16-AF3C-06594196929F Q55031285-22CDC9F4-3793-4324-A736-AAFBF4FD637A

P2860

Protein modification by aldehydophospholipids and its functional consequences.

http://www.wikidata.org/entity/Q37997263

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Protein modification by aldehydophospholipids and its functional consequences.

@en

Protein modification by aldehydophospholipids and its functional consequences.

@nl

type

label

Protein modification by aldehydophospholipids and its functional consequences.

@en

Protein modification by aldehydophospholipids and its functional consequences.

@nl

prefLabel

Protein modification by aldehydophospholipids and its functional consequences.

@en

Protein modification by aldehydophospholipids and its functional consequences.

@nl

P1433

Q37997263-9D01D8CD-B949-4504-9DBD-AA6096E8047E

P1476

Q37997263-314BE5E7-347C-4200-AE82-82946CD5EBB3

P2093

Q37997263-31E7705B-E745-4203-8C3C-E11E97704DE6

Q37997263-C287DA4D-1BD0-423F-935E-5CC44AEBAB0D

P275

Q37997263-DD141A1B-3721-45C1-A9BC-2184AEBBD461

P2860

Q37997263-04A2A3CC-3910-4F26-A084-13F407D2AB39

Q37997263-094F764C-C876-4AE9-87E9-2210441A780E

Q37997263-0952E9E1-4A5D-4DE0-B178-AB46465ACB27

Q37997263-0D0FE3A4-5069-45E6-9E92-C77DB6A01D69

Q37997263-104CB357-3396-442C-999D-CE5BBF8063B5

Q37997263-11FFC590-6E02-4145-9195-1F701C6A2A7D

Q37997263-12ECB035-AA27-4E00-BE72-2EB14809DED0

Q37997263-1668F6E2-562C-4287-BDC1-9752EE96214F

Q37997263-1DEDB9DA-1A66-4CC1-A2BE-7C45C91EE126

Q37997263-1E34957B-3AE3-4263-B39A-7E033E1CD25F

P304

Q37997263-BC2C3845-190A-470C-98AC-A4CA426264FB

P31

Q37997263-0A5EF154-356E-4709-890D-6829777C1B94

Q37997263-33F993EF-4398-45C0-83DE-256BE6622E74

P356

Q37997263-33F756CC-454A-42C8-9703-0A7E802C119D

P407

Q37997263-5B3AB034-68C1-4417-8883-51C34712F5C0

P433

Q37997263-743B57BA-291B-4E62-B4AE-E5BD158E77BA

P478

Q37997263-7FFB570E-1ACF-40F8-B790-AFDDCA76205A

P577

Q37997263-2C7195A7-4055-460E-A571-0E5E28B24F33

Q37997263-59A3AB3C-95F3-4B5E-B209-ED9311A22115

P5875

Q37997263-0DD5B85A-E567-454E-B6FD-0877AC4ED506

P698

Q37997263-57B815F5-9237-4000-B3BE-9D5543FCA4A2

P921

Q37997263-24A57D0C-0197-4781-84CB-0136A2973BB4

Q37997263-81313D13-766A-4976-B1A6-2A84596A0EA2

Q37997263-8EA4CDF6-5730-4221-A372-B152816B3B72

P932

Q37997263-84CF3CD3-B2F7-4B0E-9261-83CE705CE66B

P356

J.BBAMEM.2012.03.006

P1433

Biochimica et Biophysica Acta

P1476

Protein modification by aldehydophospholipids and its functional consequences.

@en

P2093

Albin Hermetter

http://www.w3.org/2001/XMLSchema#string

Ute Stemmer

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

P2860

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Structural characterization of oxidized phospholipid products derived from arachidonate-containing plasmenyl glycerophosphocholine

Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells

The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein

Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36

Atherosclerosis. the road ahead

Import and fate of fluorescent analogs of oxidized phospholipids in vascular smooth muscle cells.

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.

Low density lipoprotein undergoes oxidative modification in vivo.

Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway

P304

2436-2445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBAMEM.2012.03.006

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

1818

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221981837

http://www.w3.org/2001/XMLSchema#string

P698

22450235

http://www.w3.org/2001/XMLSchema#string

P921

regulation of gene expression

P932

3790970

http://www.w3.org/2001/XMLSchema#string